n-valyltryptophan has been researched along with flavone in 1 studies
Studies (n-valyltryptophan) | Trials (n-valyltryptophan) | Recent Studies (post-2010) (n-valyltryptophan) | Studies (flavone) | Trials (flavone) | Recent Studies (post-2010) (flavone) |
---|---|---|---|---|---|
13 | 0 | 6 | 566 | 1 | 268 |
Protein | Taxonomy | n-valyltryptophan (IC50) | flavone (IC50) |
---|---|---|---|
Poly [ADP-ribose] polymerase tankyrase-1 | Homo sapiens (human) | 0.3243 | |
Poly [ADP-ribose] polymerase 1 | Homo sapiens (human) | 1.3902 | |
Androgen receptor | Homo sapiens (human) | 5.9 | |
Aromatase | Homo sapiens (human) | 6.0027 | |
Dipeptidyl peptidase 4 | Homo sapiens (human) | 0.17 | |
Cytochrome P450 1B1 | Homo sapiens (human) | 0.6 | |
Poly [ADP-ribose] polymerase tankyrase-2 | Homo sapiens (human) | 0.144 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Guo, CL; Guo, SJ; Jiang, B; Li, N; Li, XQ; Shi, DY; Wang, LJ | 1 |
1 review(s) available for n-valyltryptophan and flavone
Article | Year |
---|---|
Recent progress of the development of dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes mellitus.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Humans; Hypoglycemic Agents; Molecular Docking Simulation; Structure-Activity Relationship | 2018 |